| http://www.w3.org/ns/prov#value | - Two-thirds of its business is ex-US, and the firm has secured public funding for Soliris in such jurisdictions as Australia and Canada???two countries well known for being perhaps even more restrictive than the EU. he is not a slam dunk given that the drug costs about $440,000 per patient per year (it is sometimes given away, in cases of hardship).
|
